Moderna 2022 Priorities and Capital Allocation
First quarter 2022 GAAP financial results
QoQ Change
In $ millions, except per share amounts (unaudited)
Q1 2022
Q1 2021
(Q1'22 vs. Q1'21)
Product sales
$
5,925
$
1,733
$
4,192
242 %
Grant revenue
Collaboration revenue
126
194
(68)
(35) %
15
10
5
50 %
Total revenue
6,066
1,937
4,129
213 %
Cost of sales
Research and development
Selling, general and administrative
Total operating expenses
Income from operations
Other income (expense)
Provision for income taxes
Net income
Earnings per share - Diluted
Weighted average shares - Diluted
Effective tax rate
1,017
193
824
427 %
554
401
153
38 %
268
77
191
248 %
1,839
671
1,168
174 %
4,227
1,266
2,961
234 %
2
(6)
8
133 %
572
39
533
1,367 %
St A
$
3,657
$
1,221
$
2,436
200 %
$
8.58
2.84
5.74
426
430
(4)
202 %
(1)%
14 %
3%
Slide 30
modernaView entire presentation